News for Immunovant Inc Stock (IMVT)

IMVT SHAREHOLDER LAWSUIT DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Immunovant, Inc.

PRNewsWire • 03/18/21

INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

PRNewsWire • 03/17/21

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Newsfile Corp • 03/15/21

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Newsfile Corp • 03/12/21

SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Newsfile Corp • 03/11/21

ROSEN, A TOP RANKED LAW FIRM, Encourages Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation Investors to Secure Counsel Before Important Deadline – IMVT, HSACU, HSAC, HSACW

GlobeNewsWire • 03/09/21

Immunovant (IMVT) Gains on a Potential Buyout by Roivant

Zacks Investment Research • 03/09/21

Why Immunovant, Anchiano, OpGen Are Rallying Today

Benzinga • 03/08/21

Why Immunovant Stock Is Soaring Today

The Motley Fool • 03/08/21

IMVT Stock Price Increased Over 44% Intraday: Why It Happened

Pulse2 • 03/08/21

IMVT INVESTOR FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Immunovant, Inc.

GlobeNewsWire • 03/07/21

ROSEN, A LEADING LAW FIRM, Encourages Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline – IMVT, HSACU, HSAC, HSACW

Business Wire • 03/06/21

SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Immunovant, Inc. – IMVT, HSACU, HSAC, HSACW

GlobeNewsWire • 03/05/21

IMVT Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Immunovant, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm

Business Wire • 03/05/21

ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline – IMVT, HSACU, HSAC, HSACW

GlobeNewsWire • 03/03/21

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation (IMVT)

Business Wire • 03/03/21

IMVT INVESTOR DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Immunovant, Inc.

GlobeNewsWire • 03/02/21

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation (IMVT)

Business Wire • 03/01/21

BREAKING ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation Investors to Secure Counsel Before Important Deadline – IMVT, HSACU, HSAC, HSACW

Business Wire • 02/25/21

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation (IMVT) Investors

Business Wire • 02/25/21

IMVT INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Immunovant, Inc.

GlobeNewsWire • 02/25/21

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation (IMVT) Investors

Business Wire • 02/24/21

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation (IMVT) Investors

Business Wire • 02/24/21

Shareholder Alert: Robbins LLP Announces That Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation (IMVT) is Being Sued for Misleading Shareholders

Business Wire • 02/23/21

The Law Offices of Frank R. Cruz Announces Investigation of Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation (IMVT) on Behalf of Investors

Business Wire • 02/23/21